These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8534633)

  • 1. Intravesical instillation of oxybutynin in women with idiopathic detrusor instability: a randomised trial.
    Enzelsberger H; Helmer H; Kurz C
    Br J Obstet Gynaecol; 1995 Nov; 102(11):929-30. PubMed ID: 8534633
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
    O'Flynn KJ; Thomas DG
    Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
    Enzelsberger H; Kurz C; Helmer H; Mittermayer F
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical use of oxybutynin hydrochloride in women with urge incontinence].
    Enzelsberger H; Kurz C; Helmer H
    Gynakol Geburtshilfliche Rundsch; 1994; 34(1):23-4. PubMed ID: 8019165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical oxybutynin chloride: experience with 42 patients.
    Weese DL; Roskamp DA; Leach GE; Zimmern PE
    Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients.
    Haferkamp A; Staehler G; Gerner HJ; Dörsam J
    Spinal Cord; 2000 Apr; 38(4):250-4. PubMed ID: 10822396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction.
    Vaidyananthan S; Soni BM; Brown E; Sett P; Krishnan KR; Bingley J; Markey S
    Spinal Cord; 1998 Jun; 36(6):409-14. PubMed ID: 9648197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of intravesical and oral oxybutynin chloride.
    Massad CA; Kogan BA; Trigo-Rocha FE
    J Urol; 1992 Aug; 148(2 Pt 2):595-7. PubMed ID: 1640530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravesical drug therapy in women with severe urge incontinence. Clinical experiences from a department of gynecology].
    Johansen JK; Lose G
    Ugeskr Laeger; 1999 Nov; 161(44):6052-5. PubMed ID: 10778341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
    Amark P; Bussman G; Eksborg S
    Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
    Lehtoranta K; Tainio H; Lukkari-Lax E; Hakonen T; Tammela TL
    Scand J Urol Nephrol; 2002 Feb; 36(1):18-24. PubMed ID: 12002352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients.
    Connor JP; Betrus G; Fleming P; Perlmutter AD; Reitelman C
    J Urol; 1994 Apr; 151(4):1045-7. PubMed ID: 8126787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
    Von Zweigbergk M; Nordin B; Jonsson S
    Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
    Greenfield SP; Fera M
    J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case 7: the addled nonagenarian.
    Shader RI; Oesterheld JR
    J Clin Psychopharmacol; 1995 Oct; 15(5):378. PubMed ID: 8830074
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxybutynin with bladder retraining for detrusor instability in elderly people: a randomized controlled trial.
    Szonyi G; Collas DM; Ding YY; Malone-Lee JG
    Age Ageing; 1995 Jul; 24(4):287-91. PubMed ID: 7484484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
    Lose G; Nørgaard JP
    BJU Int; 2001 Jun; 87(9):767-73. PubMed ID: 11412211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.